The Na+-regulating and vasoactive peptide hormone atrial natriuretic peptide (ANP) has been localized in cultured glial cells from neonatal rat brain but has not been reported in situ in adult brain. In the present study, immunohistochemical localization of ANP in astrocytes of adult canine brain was obtained using an antibody against rat A N F W, a 25-amho acid fragment identical to low molecular weight brain ANP.
Introduction
Atrial natriuretic peptide (ANP) is a polypeptide hormone secreted by the cardiac auia (8) with potent natriuretic/diuretic and vasorelaxant properties in the periphery (4, 14) . In addition to the heart, ANP has been localized by immunohistochemistry in several tissues including the salivary glands, kidney, anterior pituitary, adrenal medulla, and autonomic ganglia (5, 7, 33, 34, 40) . The existence of ANP in the central nervous system was detected by radioimmunoassay in homogenates of rat hypothalamus (53) and subsequently mapped in neurons ofthe rat brain by several laboratories (21, 26, 49) . Similar immunohistochemical mapping of ANP has also been reported for the frog brain (39).
Recent studies have shown that components of the brain renin-angiotensin system (RAS), specifically renin and angiotensinogen, are synthesized by a subpopulation of astroglia (15,16,20,51). Angiotensin I1 (A 11), the octapeptide end-product of the RAS and a potent endogenous antagonist of ANP, has also been localized in astrocytes by immunohistochemistry (15). Other neuropeptides and neurohormones that have been detected in astroglia include enkephalins (35,54,56), somatostatin (46), and endothelin (9,29). It was hypothesized, therefore, that ANP might also be localized in astroglia. However, previous studies (21, 26, 49) , as well as our own investigations, failed to detect ANP in glial cells of the adult rat brain with immunohistochemical techniques.
Supported in part by a Howard University Faculty Research Support
Grant and by NIH grant R29 H I . 45241-01. The canine brain was chosen for this study because dogs have routinely been used in studies of peripheral and central cardiovascular regulation and because the canine brain has a functional and well-characterized RAS (for review see 18). In addition, we have recently mapped the distribution of ANP-like immunoreactive (ANP-LIR) neurons in the canine brain (McKenzie and Cowie, manuscript in preparation).
Materials and Methods
Mixed breed (beagle-like) adult dogs (n = 7) were injected with sodium heparin (3000 U, IV) and deeply anesthetized with intravenous administration of sodium pentobarbital (80 mg/kg, W ) . Each dog was perfused intracardially with physiological saline and 10% neutral buffered formalin fixative, followed by 0.1 M phosphate buffer (pH 7.4) containing 10% sucrose as a cryoprotectant. The brain was removed and blocks were immersed at 4'C in 0.1 M phosphate buffer containing 35% sucrose until saturated. Frozen sections of30-50 vm were collected sequentially in phosphate buffer at 4'C. Six brains were sectioned in the coronal and one in the sagittal plane. Immunohistochemical staining was performed by the avidin-biotin-peroxidase complex (ABC) technique (Vectastain Elite; Vector Laboratories, Burlingame, CA) using a previously well-characterized antibody against synthetic rat ANF IV (a gift from Dr. lidashi Inagami). Rat ANFIV with the amino acid sequence HzN-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-lle-As~Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-~g-Tyr-COOH (36, 37) was synthesized by a solid-phase method and purified by chromatography (52). ANF-IV is contained within the rat ANP[1-28] sequence and is identical to the low molecular weight form isolated from rat brain (13, 47) . ANF-IV was coupled with thyroglobulin and injected intradermally in Dutch belted rabbits (53). Antisera against synthetic ANFIV crossreacted 100% with natural ANF-IV, 100% with rat ANFII, 42.5% with human ANP (ahANP ), and 28% with atriopeptin I, but did not crossreact with arginine vasopressin, angiotensin I (A I), or angiotensin I1 (A 11) (34). This antibody has proved to be much more sensitive than commercially available antibodies for immunohistochemistry and provided the first immunohistochemical localization of ANP in anterior pituitary, adrenal medulla, and kidney (33,34), and the first demonstration of ANP in the rat brain by radioimmunoassay (53).
Free-floating sections were pre-incubated in PBS, pH 7.4. containing 3% normal goat serum (NGS) and 0.3% Triton X-100 for 30 min at room temperature, and then transferred to PBS containing 1.5% NGS, 0.3% Triton, and primary antibody (1:10,000) for 72 hr at 4%. After washing (three times for 5 min in PBS10.196 Triton), sections were incubated for 30 min in biotinylated goat anti-rabbit IgG (1:200) in PBS/0.3% Triton. The tissue was then washed as above and incubated for 30 min in PBS containing 1% H202. washed, and incubated for 30 min in ABC complex in PBS/.0.3% Triton. Finally, the sections were incubated for 5 min in 0.05 M Tris bu&r (pH 7.2) containing diaminobenzidine (35 mg%) and H202 (0.005%), and washed overnight in tap water. Sections were mounted on large glass slides, dehydrated, cleared in xylene, and coverslipped. Substitution of normal rabbit serum for primary antibody served as a control. As an additional control, the antiserum was pre-absorbed with brain natriuretic peptide (BW, Peninsula Laboratories, Burlingame, CA; 10 pglml, 48 hr, 4'C). To verify the identity of these cells as astrocytes, some sections were stained by the above protocol with an antibody against glial fibrillary acidic protein (GFAP; Dako, Carpenteria, CA; 1:lOOO).
Dimensions of A"-positive glia from sections of four brains were obtained by measurements of cell widths and the lengths of processes with a calibrated eyepiece micrometer disc. The initial measurement was made in the longest axis of the cell and the second in the longest perpendicular axis. Measurements of astroglial Types I and I1 included the full extent of processes in both axis. Measurements of ANFpositive astrocytes (Type 111) forming part of the glia limitans (GL) included the aggregated processes within or immediately adjacent to the GL but did not indude separate processes extending into the brain parenchyma. A total of SO5 ANP-positive astroglia were observed, measured, and characterized from 197 random sections, as described in Eble 1. The density of ANP-positive astroglia was also compared with the distribution of GFAP-immunoreactive astroglia in similv sections. Data wcre collected and organized, and means and standard ertors were calculated, with the aid of Cricket Graph and Statworks software (Cricket Software; Malvern, PA) using MacIntosh SE and IIci computers.
The guides for the care and use of laboratory animals from the National Research Council and the Howard University Animal Care and Use Committee were followed in the above experiments.
Results
Astrocytes immunopositive for ANP were found in small numbers (505 ANP-positive cells out of a total of 197 hemisphere sections) (Table 1) throughout the canine brain, including the cerebellum, but appeared most numerous in the neocortex. ANP-like immunoreactive (ANP-LIR) astroglia were a very small subgroup of GFAP-positive asuoglia (<1.0%) but consisted of three separate subpopulations. Members of the largest subpopulation (75% of the total ANP-LIR astroglia) were spheroid to ovoid in shape (mean f SEM; 84.1 2 3.2 pm x 65.1 f 1.9 pm; range 39 x 39 pm to 150 x 122 pm) and had the appearance of densely packed balls of immunoreactive processes (Figures la and lb). As these astroglia were found in cellular areas such as the cortical gray matter or hypothalamus, they were judged to be astrocytes of the protoplasmic subtype (Type 1). Because of the thickness of the sections and the intensity of staining, cell bodies were not always distinct. Specimens of this group were found in all cortical layers and were almost always observed associated with blood vessels, frequently at sites of vascular branching ( Figure 2 ). The AM-LIR cells appeared to have similar dimensions to astrocytes stained for GFAP (Figures 3a and 3b). A second subpopulation (19% of the total ANP-positive cells) of larger (140.6 4.4 pm x 84.8 f 5.6 pm; range 47 x 32 pm to 390 x 157 pm) ANP-LIR astroglia occurred exclusively in white matter. They consisted of long, less densely packed processes and resembled astrocytes of the fibrous subtype (Type 11) ( Figures  4a and 4b ). These cells also frequently appeared to make direct contact with blood vessels or sent long, filamentous processes towards neighboring microvessels ( Figure 4a ). Frequently, varicosities were observed on the processes of these cells ( Figure 4b ). The least numerous subpopulation of ANP-LIR glia (6% of ANP-positive astroglia) consisted of a small percentage of the astrocytes forming the glia limitans (GL) ( Figures Sa and 5b) . These cells, which are a specialized subset of Type I astrocytes, were flattened (86.8 9.0 pm x 45.1 2 2.6 pm; range 32 x 19 pm to 190 x 27 pm) and often sent long (174.7 2 28.0 pm) filamentous or thicker processes into the brain parenchyma. The processes often terminated in club-like or fimbriated endings (Figure 5b ). These cells also frequently demonstrated apparent intimate relationships to blood vessels (not shown). The immunoreactive processes of the ANP-LIR astroglia of the glia limitans were very similar in appear-ance to GFAP-immunostained preparations (Figures 6a and 6b ).
The staining for ANP in all three astrocyte subtypes appeared to be evenly distributed throughout the cell body and processes. Because of their relatively low population density, it was unusual to find more than one ANP-positive astrocyte of any subtype in a low-power microscopic field. In a fcw cases, two positive astroglia were seen together. However, in the right hemisphere of one dog brain, dozens of ANP-positive glia of all three types were found clustered around the anterior and posterior rhinal fissures in as- (Figures 7a and 7b ). The contralateral hemisphere possessed a normal density of ANP-LIR astroglia (not shown).
The morphology of the ANP-positive Type I astroglia seemed to be at lest partially determined by their location or by the arrangement of the surrounding parenchyma. In some cortical areas, ANP-LIR Type I astrocytes were usually spherical in superficial layers but tended to flatten and become ovoid in deeper layers of the gray matter until they resembled Type I1 astrocytes of the white matter in shape (Figure 7a ). In the septum, some ANP-positive astrocytes adjacent to the lateral ventricle possessed a morphology similar to that of Type 111 immunopositive glial of the glia limitans (not shown). Staining of all astroglial subtypes varied in intensity in parallel with antibody concentration and was absent in controls. Staining was not eliminated by absorption ofthe antibody with BNP.
Discussion
The results of the present study indicate the existence in vivo of immunoreactive ANP-like peptide in several subpopulations of astroglia in the canine brain. The failure of the antibody to absorb with BNP indicates that the antibody recognizes ANP or an ANPlike peptide, not BNP. When comparisons were made with similar sections of dog brain stained immunohistochemically for glial fibrillary acidic protein (GFAP), it was apparent that fewer than 1% of the astroglia present in each section stained positively for ANP. This may represent a functional heterogeneity in the astrocyte population, as has recently been demonstrated for synthesis of angiotensinogen (51) and endothelin (9) in primary astrocyte culture. The relative scarcity of ANP-positive astroglia also suggests that these cells may only transiently express ANP or may synthesize ANP only in response to physical, hormonal, or other stimuli. Therefore, the single large group of positive astroglia observed around the rhinal fissure of one dog brain in the present study may represent such a focal reaction to an unknown stimulus.
Although similar in dimensions, ANP-LIR astroglia, particularly those of the gray matter, presented a much different appearance from those stained for GFAP but were similar to those stained for angiotensinogen (20). This difference may be attributable to the differing location of antigenic sites within the cell. It is also interesting to note that although Type I and Type I1 astrocytes originate from different progenitors (41.42) both types are immunopositive for ANP.
Raizada and colleagues (43) have recently published a report of ANP immunoreactivity in glial cells cultured from neonatal rat brain which corroborates the results of the present study and those published earlier in abstract form (32). Raizada and co-workers established primary glial cultures from neonatal rat hypothalamuslbrainstem and detected immunoreactive ANP in both the glial cells and the culture medium. The ANP extracted from the medium co-eluted with low molecular weight ANP on HPLC. These investigators also immunohistochemically stained isolated cultured astroglia for ANP in vitro, but the relative proportion of ANP-positive glial cells in the total population was not reported. The stained astroglia (43) bore a striking resemblance to the appearance of ANP-LIR fibrous (Type 11) astroglia reported in the present study. A significant decrease (two-to fourfold) in cellular ANP and ANP extracted from the culture medium of glia isolated from the brains of neonatal spontaneously hypertensive rats (SHR) compared with Wistar-Kyoto (WKY) controls was also observed (43). This evidence strongly supports the validity of the immunohistochemical localization of ANP in the adult canine brain as reported in the present study. Furthermore, these results indicate endogenous synthesis and secretion of ANP by astroglia and suggest a possible involvement of astroglia in the pathogenesis of genetic hypertension.
The localization of ANP in glial cells may be significant for several reasons. It may not be merely fortuitous that, of the very few other putative peptide neurotransmitterslneuromodulators identified in glia to date, the most prominent has been A I1 (or other components of the RAS) (15J6.20). Imboden and colleagues (20) suggesteL two possible functions for glial angiotensinogen based on the close relationship of astroglia with brain microvessels. In the first, it was hypothesized that astroglia may secrete angiotensinogen into the microvessel lumen where it would be converted to A I1 and serve as a regulator of local cerebral blood flow. The close proximity of processes of ANP-positive glia with microvessel walls described in the present study makes this hypothesis attractive for ANP as well. Astrocytes have previously been demonstrated to regulate the formation of the blood-brain barrier by endothelial cells (24) . ANP secreted from astrocyte processes in the vicinity of the vascular wall may alter local microvascular permeability, thus regulating the passage of fluids/electrolytes through the blood-brain barrier (6, 50) . Recently, both ANP and BNP (brain natriuretic peptide) have been demonstrated to inhibit thrombin-induced permeability in endothelial monolayers by a cGMP-dependent mechanism (28) .
The hypothesis that ANP may affect the cerebral vasculature is further supported by the presence of functional (guanylate cyclasecoupled) ANP receptors on cerebral microvessels (3,6,30,50) . Per-haps most important, guanylate cyclase has also been localized on the basal as well as the luminal membranes of brain microvessels (25) . Since it has recently been reported that ANP inhibits amiloride-sensitive Na+ transport in brain capillary endothelium by interaction with luminal receptors (19). it can be postulated that ANP of astrocytic (or other endogenous) origin may have a similar function at the basal membrane. This is further supported by the inability of plasma ANP to cross the blood-brain barrier (27) and the previously noted effects of ANP on endothelial permeability (28) . Therefore, ANP secreted from the processes of astroglia and interacting with guanylate cyclase-linked receptors on the ablumi- nal aspect of the microvessel endothelium may protect against the formation of edema by inhibiting brain microvessel permeability.
The alternate hypothesis of Imboden and co-workers (20) suggested that neurons internalized angiotensinogen secreted by the astroglia. The angiotensinogen may have been either synthesized within the astroglia or, through the intimate contacts with blood vessels, transferred from the plasma. The results of the present study argue against such a relationship for ANP-positive astroglia and neurons. Although the astroglia described in this study were usually observed to be associated with blood vessels, they were neither concentrated in regions with high densities of immunopositive neurons nor were they except rarely observed in direct contact with or even in the near vicinity of ANP-positive neurons or neuronal processes. In addition, as noted above, ANP does not normally cross the blood-brain barrier.
It is possible that the immunohistochemical staining for ANP associated with asuoglia in the present study may represent receptorbound and internalized ANP rather than ANP synthesized by the astroglia. However, the antibody used in these studies did not detect ANP bound to renal glomerular receptors or internalized in glomerular cells (33).
[ 12sI]-ANP binding sites have been visualized autoradiographically on glial cells cultured from mouse spinal cord (48) and rat sympathetic ganglia (22), as well as on glial cells associated with intracardiac neurons in cultures from dissociated guinea pig atria (23). The presence of such binding sites was first suggested by evidence that ANP increased intracellular cGMP in glial tumor cells and in astroglia-rich cultures from rat and mouse brain (10,ll).
In addition, ANP has been demonstrated to alter membrane polarity in cultured rat glioma cells (45). A recent report has identified the majority of ANP receptors on cultured rat astrocytes as clearance (Type C) receptors which may regulate the availability of ANP to neurons involved in cardiovascular regulation and fluidlelectrolyte balance (2). However, the sparse but ubiquitous distribution of ANP-LIR astroglia observed in the present study makes this an unlikely hypothesis for these particular cells, as noted above. Astroglial ANP receptors may play a role in autocrinelparacrine regulation of astroglial ANP synthesis or in the regulation of the synthesislsecretion of other neuropeptides. A similar role has been proposed for the regulation of A I1 synthesis by A I1 receptor-positive astroglia (44) and for endothelin-3 synthesis in endothelin receptor-positive astrocytes (9).
The importance of putative neuropeptides, especially those involved in cardiovascular regulation and fluidlelectrolyte balance, in the regulation of glial function should not be underestimated. Yu and colleagues (57) have stated [referring to Hossmann (17)] that, "Dysfunction of astrocytes would lead to a sequence of pathological events such as loss of cellular volume control, and increase of brain tissue volume, both cellular and vasogenic edema, a rise in intracranial pressure, cerebral herniation and finally, arrest of cerebral circulation." ANP, through the mediation of cGMP, its inuacellular second messenger, may regulate astroglial structure and the contacts of glial processes with cerebral blood vessels. The shape ofastrocytes in culture is altered by a wide miety of hormones and growth factors. For example, the addition of insulin and P-fibroblast growth factor (PFGF) to serum-free medium transforms flat, polygonal astrocytes into stellate cells with multiple processes and is associated with new synthesis of glial fibrillary acidic protein (GFAP) (38). This hypothesis is currently being tested for ANP.
The significance of ANP immunoreactivity in astrocytes comprising a portion of the glia limitans (GL) remains obscure. Although these cells stained intensely for ANP, they appeared to represent only a very small minority (<1.0%) of the total number of cells contributing to this structure. However, it is possible that the actual percentage of these cells in the total ANP-positive astroglial population may be higher, as fragments or partial profiles may not have been recognized in the darker-staining GL and therefore not counted. The GL has previously been assumed to be a syncytium of astroglial cell bodies and processes linked by gap junctions and forming a barrier to neuronal elements (1). However, we have recently demonstrated (31) that both axons and dendrites of ANPpositive cortical neurons may traverse this layer to terminate in the vicinity of pial blood vessels. Since the pia, and possibly the adjoining GL, possesses a dense population of specific ANP binding site (3,30), it is possible that ANP secreted by astrocytes of the GL regulates the proposed barrier and ionic redistribution properties or other functions of these structures (12, 5 5) . In addition, the presedce of long processes extending from these cells to the vicinity of parenchymal blood vessels or other structures suggests the possibility of communication between the external and internal fluid environments of the brain.
In conclusion, the results of the present preliminary study indicate that specific astroglial cells in the canine brain may serve as an anatomic substrate for the synthesis and secretion of ANP which may exert its effects directly at the blood-brain barrier or through interaction with specific ANP receptors on neurons and/or other astrocytes (2,ll). Electron microscopic and biochemical studies are presently under way to further characterize these cells. It is hoped that cultured astrocytes will serve as a model system for further studies of the regulation of ANP synthesis and secretion. The importance of astrocytic ANP in the maintenance of brain fluidlelectrolyte homeostasis remains to be determined.
